Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Quick Answer: Tirzepatide commonly causes loose stools and diarrhea in 13-24% of patients, typically mild to moderate and resolving within weeks of treatment initiation or dose escalation
This off-label approach aims to minimize gastrointestinal side effects such as nausea and vomiting, while potentially promoting weight loss or maintaining metabolic benefits, often considered for sensitive individuals
Not everyone responds the same way to GLP-1 therapies, and some individuals may find the side effects outweigh the benefits
Cheng, F
US$ 24.78
US$ 21.14
US$ 26.92
US$ 21.62
US$ 23.87
US$ 22.88
US$ 20.45
US$ 21.69
